NCT00001894View on ClinicalTrials.gov

A Comparison of Two Treatments: Pacemaker and Percutaneous Transluminal Septal Ablation for Hypertrophic Cardiomyopathy

PHASE2CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

August 31, 1999

Study Completion Date

September 30, 2002

Conditions
Hypertrophic Cardiomyopathy
Interventions
PROCEDURE

pacemaker implantation

PROCEDURE

percutaneous transluminal septal ablation (PTSA)

Trial Locations (1)

20892

National Heart, Lung and Blood Institute (NHLBI), Bethesda

All Listed Sponsors
lead

National Heart, Lung, and Blood Institute (NHLBI)

NIH

NCT00001894 - A Comparison of Two Treatments: Pacemaker and Percutaneous Transluminal Septal Ablation for Hypertrophic Cardiomyopathy | Biotech Hunter | Biotech Hunter